SCHEMBL14115659

SCHEMBL14115659

COC(=O)Cc1c(OC)ccn(C(c2ccccc2)c2ccccc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ EGFR P00533 1/20 0.39
▸ PLA2G4A P47712 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ TNF P01375 1/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ TSHR P16473 1/20 0.36
▸ LTB4R Q15722 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432234 0.78 OPRD1 (0.40) ALDH1A1L3MBTL1PLA2G4AGAAMEN1
SCHEMBL4429455 0.68 TSHR (0.44) ALDH1A1KDM4EKMT2ATSHRCRHBP
SCHEMBL28652312 0.67 KDM4E (0.48) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL468013 0.65 MEN1 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL30027909 0.65 MEN1 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL28639201 0.65 GAA (0.40) SMN1; SMN2ALDH1A1KDM4EGAAMEN1
SCHEMBL4986643 0.64 OPRD1 (0.47) RAB9AALDH1A1L3MBTL1GAAMEN1
SCHEMBL31446775 0.64 SMN1; SMN2 (0.50) SMN1; SMN2NPC1ALDH1A1MEN1KMT2A
SCHEMBL22807323 0.64 SMN1; SMN2 (0.50) SMN1; SMN2NPC1ALDH1A1MEN1KMT2A
SCHEMBL27510108 0.64 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1L3MBTL1EGFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188528-A1 Modulators of C3a receptor and methods of use thereof ENCYSIVE PHARMACEUTICALS, INC. 2008-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188528-A1 Modulators of C3a receptor and methods of use thereof C3AR1, C5, C5AR1 SMN1; SMN2 2273/4885NPC1 4103/4885RAB9A 4312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback